Amended guidelines now allow pharmaceutical firms to avoid court appearances for minor offences by paying a monetary penalty ...

These days everyone wants to know exactly what's passing between pharmaceutical companies and doctors: Down to the cheapest pen, they want to know how doctors might be influenced by pharma. So, to ...

Picture yourself as the head of an R&D organization which is planning to embark on a multi-year, $500 million clinical program for a new drug to slow Alzheimer’s Disease. Before making this ...